Mumbai-based Zuventus Healthcare has become the first company globally to commercially launch aviptadil, over 50-year old drug molecule, for treating acute respiratory distress syndrome (ARDS).
The drug was discovered by Dr Sami Said, pulmonary medicine specialist, in 1970. Aviptadil a complex peptide-was not commercially used for ARDS, though prescribed as a last resort (orphan drug); it is prepared by Universities for emergency use by hospitals, the company said.
Denne historien er fra November 26, 2022-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 26, 2022-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Qcom firms' foray into food biz rustles up restaurants
The Federation of Hotel & Restaurant Associations of India (FHRAI) on Friday said it will approach the commerce ministry to discuss private labelling of food items by Zomato and Swiggy through their recently-launched quick-food delivery platforms, Bistro and Snacc, respectively.
From Russia With Love
Indian refiners may face a windfall this year from falling Urals oil rates even as US levies sanctions on Russian firms. Will motorists benefit?
Meta's Fact-Check Shift in US Sparks Misinformation Fears in India
Meta's decision to discontinue its fact-checking programme in the United States has raised concerns among its partners in India, prompting many to reconsider their strategies.
SECTOR-THEMATIC NFOs Beware lack of track record, cyclicality, concentration risk
To capitalise on the bull market, mutual fund houses launched 202 new fund offers (NFOs) in 2024, a record high, according to data from Morningstar.
Short on funds? Book flights with 10-40% upfront & pay the rest later
Short of funds for an international trip? You can book your flight with just 10 to 40 per cent upfront payment.
Brokerages Upbeat on TCS After Q3 Miss
They highlight optimistic outlook and attractive valuation
Bombay Burmah, Wadias settle matter with Sebi for ₹2.1 cr
Bombay Burmah Trading Corporation, its promoters Nusli Wadia, his sons Ness Wadia and Jehangir Wadia, along with 14 others settled a matter with the Securities and Exchange Board of India (Sebi) for alleged violations of three regulations by paying the total settlement amount of ₹2.13 crore.
$35 bn IPOs in the pipeline this year: Kotak I-Banking
The momentum in the equity market is likely to continue with initial public offerings (IPOs) worth $35 billion in the next 12 months, Kotak Investment Banking said on Friday.
FPIs exit India debt market as bond yield gap with US shrinks
Foreign portfolio investors (FPIs), which returned to the domestic debt market in December after two consecutive months of net selling, started withdrawing again in January.
Record 4.5 million SIP closures in Dec, inflows stay strong
Investors are shutting down mutual fund (MF) SIP accounts at a record pace amid mounting equity market volatility.
